| Unique ID issued by UMIN | UMIN000061896 |
|---|---|
| Receipt number | R000070823 |
| Scientific Title | Verification of ADH1B and ALDH2 Gene Polymorphisms Affecting Severe Alcoholic Hepatitis: A Multicenter Study |
| Date of disclosure of the study information | 2026/06/13 |
| Last modified on | 2026/06/13 16:11:59 |
A Multicenter Observational Study on the Relationship between Severe Alcoholic Hepatitis and Alcohol-Metabolizing Gene Polymorphisms (ADH1B and ALDH2)
SAH-GENE study
Verification of ADH1B and ALDH2 Gene Polymorphisms Affecting Severe Alcoholic Hepatitis: A Multicenter Study
SAH-GENE study
| Japan |
Severe Alcoholic Hepatitis
| Hepato-biliary-pancreatic medicine |
Others
YES
Severe alcoholic hepatitis (SAH) is a rare and extremely poor-prognosis condition characterized by acute jaundice, marked inflammatory response, and multi-organ failure, occurring in a small subset of patients with alcoholic hepatitis associated with chronic heavy alcohol consumption. A clinically important issue is that "only a fraction of patients with comparable drinking histories develop severe acute-type disease," which highlights the rarity and heterogeneity of this condition.
In East Asian populations, functional polymorphisms in ADH1B and ALDH2, enzymes involved in ethanol metabolism, are highly prevalent and have been reported to influence various disease phenotypes including flushing response, alcohol dependence, and liver injury (Tadokoro, Nakahara, et al. 2025). However, the extent to which these genetic differences in alcohol metabolic capacity, unique to East Asian populations, determine the onset of SAH has not been investigated. The aim of this study is to identify alcohol metabolism gene polymorphisms specific to SAH.
Others
Verification of the association between gene polymorphisms and the risk of SAH onset and severity
Association between ADH1B low-activity / ALDH2 active genotype and the onset of severe alcoholic hepatitis (SAH)
Observational
| 20 | years-old | <= |
| Not applicable |
Male and Female
Patients aged 20 years or older hospitalized for alcohol-induced liver injury. Written informed consent obtained.
Patients who do not provide informed consent for genetic testing. Patients whose primary liver disease is attributed to other etiologies such as HBV, HCV, or autoimmune hepatitis.
40
| 1st name | Tomoko |
| Middle name | |
| Last name | Tadokoro |
Kagawa University Faculty of Medicine
Department of Gastroenterology and Neurology
761-0793
1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, Japan
0878985111
tadokoro.tomoko@kagawa-u.ac.jp
| 1st name | Tomoko |
| Middle name | |
| Last name | Tadokoro |
Kagawa University Faculty of Medicine
Department of Gastroenterology and Neurology
761-0793
1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, Japan
0878985111
tadokoro.tomoko@kagawa-u.ac.jp
Kagawa University
none
Other
Kagawa University Faculty of Medicine Ethics Committee
1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, Japan
0878985111
tadokoro.tomoko@kagawa-u.ac.jp
NO
| 2026 | Year | 06 | Month | 13 | Day |
Unpublished
Open public recruiting
| 2026 | Year | 04 | Month | 02 | Day |
| 2026 | Year | 04 | Month | 02 | Day |
| 2026 | Year | 04 | Month | 02 | Day |
| 2028 | Year | 09 | Month | 30 | Day |
This is a multicenter observational study without any intervention. Dried saliva samples are collected from patients hospitalized for alcohol-induced liver injury, and ADH1B/ALDH2 genotypes are analyzed by real-time PCR. The association between genotype and the onset/severity of severe alcoholic hepatitis (SAH) will be verified by comparison with GWAS data.
| 2026 | Year | 06 | Month | 13 | Day |
| 2026 | Year | 06 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070823